Literature DB >> 16394011

Oxidants selectively reverse TGF-beta suppression of proinflammatory mediator production.

Yi Qun Xiao1, Celio G Freire-de-Lima, William J Janssen, Konosuke Morimoto, Dennis Lyu, Donna L Bratton, Peter M Henson.   

Abstract

Although TGF-beta inhibits the production of proinflammatory mediators in vitro and in vivo, its anti-inflammatory activities may be ineffective in early or severe acute inflammatory circumstances. In this study, we suggest a role for oxidative stress on TGF-beta signaling, leading to prevention of its normal anti-inflammatory effects but leaving its Smad-driven effects on cellular differentiation or matrix production unaffected. Stimulation of the RAW 264.7 macrophage cells, human or mouse alveolar macrophages with LPS led to NF-kappaB-driven production of proinflammatory mediators, which were inhibited by TGF-beta. This inhibition was prevented in the presence of hydrogen peroxide. We found that hydrogen peroxide acted by inducing p38 MAPK activation, which then prevented the ERK activation and MAPK phosphatase-1 up-regulation normally induced by TGF-beta. This was mediated through Src tyrosine kinases and protein phosphatase-1/2A. By contrast, hydrogen peroxide had no effects on TGF-beta-induced Smad2 phosphorylation and SBE-luc reporter gene transcription.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16394011     DOI: 10.4049/jimmunol.176.2.1209

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signaling.

Authors:  Chunsun Dai; Xiaoyan Wen; Weichun He; Youhua Liu
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

2.  Lipopolysaccharide enhances transforming growth factor β1-induced platelet-derived growth factor-B expression in bile duct epithelial cells.

Authors:  Karen M Kassel; Bradley P Sullivan; James P Luyendyk
Journal:  J Gastroenterol Hepatol       Date:  2012-04       Impact factor: 4.029

Review 3.  The role of transforming growth factor (TGF)-β in the infarcted myocardium.

Authors:  Nikolaos G Frangogiannis
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

4.  TGFβ1 rapidly activates Src through a non-canonical redox signaling mechanism.

Authors:  Hongqiao Zhang; Kelvin J A Davies; Henry Jay Forman
Journal:  Arch Biochem Biophys       Date:  2015-01-10       Impact factor: 4.013

5.  Airway TGF-β1 and oxidant stress in children with severe asthma: association with airflow limitation.

Authors:  Sheena D Brown; Katherine M Baxter; Susan T Stephenson; Annette M Esper; Lou Ann S Brown; Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

6.  Heterotrimeric Gα(i) proteins are regulated by lipopolysaccharide and are anti-inflammatory in endotoxemia and polymicrobial sepsis.

Authors:  Hongkuan Fan; Pengfei Li; Basilia Zingarelli; Keith Borg; Perry V Halushka; Lutz Birnbaumer; James A Cook
Journal:  Biochim Biophys Acta       Date:  2011-01-19

7.  Low-intensity light therapy: exploring the role of redox mechanisms.

Authors:  Joseph Tafur; Paul J Mills
Journal:  Photomed Laser Surg       Date:  2008-08       Impact factor: 2.796

8.  Dual effect of neutrophils on pIgR/secretory component in human bronchial epithelial cells: role of TGF-beta.

Authors:  Céline Ratajczak; Amélie Guisset; Bruno Detry; Yves Sibille; Charles Pilette
Journal:  J Biomed Biotechnol       Date:  2010-07-08

9.  Transforming growth factor-beta polymorphisms and cardiac allograft rejection.

Authors:  Raymond L Benza; Christopher S Coffey; Dawn M Pekarek; Joseph P Barchue; Jose A Tallaj; Michael J Passineau; Hernan E Grenett
Journal:  J Heart Lung Transplant       Date:  2009-10       Impact factor: 10.247

10.  Lysophosphatidic acid inhibits bacterial endotoxin-induced pro-inflammatory response: potential anti-inflammatory signaling pathways.

Authors:  Hongkuan Fan; Basilia Zingarelli; Vashaunta Harris; George E Tempel; Perry V Halushka; James A Cook
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.